chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe body aches, fever, chills.  Arm pain, edema, erythema
Had no reaction after the first shot. After second shot in 10 hours developed fever up to 104.8, then dropped to normal and felt fine for three days , then on February 9 th (4th day) developed severe watery diarrhea (still going) and fever up to 102.8. Next day fever was hovering between 100 and 101, then on February 11th - 99-100. Today is first day with no fever.
Patient received the 12+ Pfizer covid biontech vaccine on 11/15/2021. The patient returned to the clinic for the second dose on 12/06/2021, however the wrong dose of covid vaccine was administered. He was given the 0.2 ml Covid vaccine for ages 5-11. The CDC has been contacted and was informed that the patient can receive the correct covid vaccine for his age range 21 days after the erroneous dose that he received on 12/06/2021. The parents will be contacted and scheduled for the correct dose of the covid vaccine.
Pt received hep A vaccien on R thigh on 11/14/02 returned 11/21/02 for f/u of bronchitis and told  about rxn. Pt had circular area around vacc site, ~ 4cm circumference that had redness and rash, pruritic, rash no resolbed, just exariation remains.
Patient received first dose of Moderna Covid 19 Vaccine at approximately 10:20AM and shortly began complaining of trouble breathing. Assessed patient. Patient denied experiencing any lightheadedness or any itching. Gave patient 2 capsules of diphenhydramine 25mg (50mg total) at approximately 10:30AM. At 10:33AM patient breathing continued to become more labored. Administered 0.3mg of epinephrine into anterior right thigh. At 10:37AM,  EMT arrived on scene and continued to monitor and evaluate patient. Patient was transported to hospital.
involuntary muscle spasms, loss of motor control, tics following Dtap.   He had this after dtap/hep B/IPV combo vaccine on 7/16 and the day after developed new tics/ movements where he extends his head
Extremely heavy menstrual cycles ever since, bleeding during luteal phase despite normal progesterone levels (had them checked). Basically I?ve been spotting or bleeding for half the month ever since my vaccine.
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated (Oka/Merck) VARIVAX dose 1, (dose, lot # and expiry date unknown). On 07-JUN-2010, patient received improperly stored (Oka/Merck) VARIVAX dose 2, from lot #665413/1128Y expiry date: 07-AUG-2011. No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provided 100 percent assurance on vaccine stability. This is one of several reports received from the same reporter. Additional information has been requested.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a female patient of an unknown age (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.            Concomitant medications were not provided. Treatment information was not reported.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
This spontaneous report as received from a registered nurse refers to a 51 year old male patient. Relevant medical history and concomitant medications were not provided. On 17-DEC-2013 the patient was vaccinated with PNEUMOVAX23 lot # J011651, subcutaneously in the right arm. Dose was not provided. Other suspect therapies included ZOSTAVAX lot # J011338, subcutaneously in the right arm and BOOSTRIX lot # T25EG, intramuscularly in the right deltoid. Dose was not provided. On 17-DEC-2013, the patient experienced achy, fever, nausea and chills. The outcome of p achy, fever, nausea and chills was reported as recovered/resolved at an unknown date. The reporter causality was unknown. This case is linked to the following cases by the same reporter: 1312USA010905, 1403USA003215, 1403USA003216, 1403USA003217, 1403USA003218, 1403USA003219, 1403USA003220, 1403USA003221, 1403USA003222, 1403USA003223, 1403USA003224, 1403USA003225, 1403USA003226, 1403USA003227, 1403USA003228, 1403USA003229, 1403USA003230, 1403USA003231, 1403USA003232, 1403USA003233, 1403USA003234, 1403USA003235, 1403USA003236, 1403USA003237, 1403USA003238, 1403USA003240, 1403USA003241, 1403USA003242, 1403USA003243, 1403USA003244, 1403USA003245, 1403USA003246, 1403USA003247, 1403USA003248, 1403USA003249, 1403USA003250, 1403USA003251, 1403USA003252 and 1403USA003253. Additional information is not expected.
This case was reported by a physician via sales rep and described the occurrence of radiating pain in a male patient who received BEXSERO for prophylaxis. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, unknown after receiving BEXSERO, the patient experienced radiating pain. On an unknown date, the outcome of the radiating pain was recovered/resolved. It was unknown if the reporter considered the radiating pain to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. The patient had radiated pain after the injection for almost a week.
Received covid shot Moderna and flu shot (unknown brand) in same arm at the same time.  Ever since has had constant dull pain in left shoulder and arm. Also gets sharp pain in left shoulder shooting down entire arm when reaching out or up.   They should not have given both shots in the same arm at the same time.  This is his spouse filling this form out. He should go to the doctor but has not gone as of yet.
Patient was feeling faint and placed on a cot with feet elevated above heart, vital signs were taken.  Vital signs were as follows:  BP was 109/74, Pulse 61.  Provided cool wet cloth and water.    Vitals were taken again: BP 120/84 and Pulse 73.  Patient was placed in sitting position for 5 minutes, patient fully recovered and released.
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.   This case was linked to MOD-2021-395985 (Patient Link).
Information has been receive from a nurse concerning four patients who were vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently, the patient experienced breakthrough chickenpox. They have about 4 to 5 lesions on their body. All four kids live in the same house. Medical attention was sought. The patients were recovering. No product quality complaint was involved. Additional information has been requested.
vasovagal episode post vaccination.  Nausea and vomiting.  Taken via ambulance to Emergency Department. Treated and released.
rash with itching at the top of her back on both sides, down each of her sides & on her arm; rash with itching at the top of her back on both sides, down each of her sides & on her arm; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 76-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, Solution for injection, Lot Number and Expiration date was not reported) via an unspecified route of administration on 09Jul2021 as dose 2, single for COVID-19 immunization (age at vaccination: 76-years-old). Medical history included, diabetes mellitus, she had a penicillin and had a reaction to it. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, Solution for injection, Lot Number: not reported, Expiry date: unknown) via an unspecified route of administration on an unknown date as dose 1, single for COVID-19 immunization. On 11Jul2021, the patient experienced rash with itching at the top of her back on both sides, down each of her sides and on her arm (rash). It was reported that it was not real severe like all over her body, she did have it with some itching. Patient states her question was she had to hold on so long to her doctor office so she just wanted to know if she could take some benadryl, she did not know if she could take it. The outcome of the events was resolving.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
One day after vaccination c/o fever and cough was seen by PCP treated symptomatically improved after 3 days.
severe tightness in chest. rapid heart beat.  sharp pains. felt like a heart attack.
Information has been received from a health professional concerning a male patient 60 to 70 years of age with no known allergies and no medical history who on 01/13/2005 was vaccinated with pneumococcal 23v polysaccharide vaccine (lot # 647660/0945N).  There was no concomitant medication.  Subsequently, about 10 to 12 hours after the injection, the patient experienced redness and swelling at injection site and whole upper arm.  The patient also experienced fever and chills.  Unspecified medical attention was sought.  There were no relevant diagnostic laboratory tests performed.  No product quality complaint involved.  Additional information has been requested.
Unknown adverse event from vaccination. 3/14/21 Informed by caregiver that client was sent by ambulance to ER and diagnosed with bilat pneumonia.  She developed difficulty breathing on 3/13/21.  She was seen at Walk In on 3/12/21 for toenail eviscerated and INR, and had been giving tylenol for pain control for toe. 3/15/21 Informed by caregiver client was in ICU, septic, bilat pneumonia, and low oxygen levels. 3/16/21 Informed by caregiver client not doing well authorized indwelling cath due to low blood pressure and ventilator.  Client transfered by med flight to ICU. 3/17/21 Informed by caregiver client death last night.
PATIENT REPORTED THIS MORNING THAT HIS CHEST GETS HURT WHEN BREATHING . HE CONTACTED PCP . HE FELT SLIGHTLY BETTER IN THE EVENING.
Arm was a bit achy later in day I received the shot but nothing bad. Started feeling chilled about 11:30 pm the day of my shot (Saturday).  Woke up about 2:30 am Sunday with chills and sweating.  Woke up several times during the night with chills and sweats. Started having slight headache during the night.  Took a couple of Tylenol.  Woke up about 9  am  day after shot (Sunday).  Was very tired but chills and sweating were gone still had slight headache.  Was exhausted remainder of day.   Just stayed in bed and rested entire day.  Started to feel better later in the evening about 8:30 pm.  Went to bed about 10:30 pm  and slept until 9 am Monday morning.  All adverse effects were gone.
guillian barre; Initial information received on 24-Dec-2022 regarding an unsolicited valid serious case received from a consumer/non-hcp via Social Media, Flu page.  This case involves patient of unknown age and gender who experienced guillian barre after receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (formulation; strength; lot number; expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient experienced a serious event of guillian barre (guillain-barre syndrome) (unknown latency) following the administration of influenza vaccine.   It was unknown if the patient experienced any additional symptoms/events  It was unknown if there were lab data/results available.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.  This event was assessed as medically significant.; Sender's Comments: Sanofi company comment for information received on 27-Dec-2022: This case involves patient of unknown age and gender who experienced guillian barre after receiving vaccine influenza vaccine. The causal role of the company suspect vaccine cannot be assessed based on the temporal relevance. Further information regarding concurrent condition during vaccination, previous vaccination, tolerance, allergic history, laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based on the data provided, the role of vaccine cannot be assessed.
No adverse event; Patient received expired Moderna Covid-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) and NO ADVERSE EVENT (No adverse event) in a 29-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 044C22A) for COVID-19 prophylaxis.     No Medical History information was reported.  On 05-Apr-2023, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 05-Apr-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine).    No concomitant medications were reported.  The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  No other adverse events were reported.  No treatment medications were reported.
Patient has history of fainting with needles and bloodword. Approximately 20 minutes after vaccine, patient was in observtion room and experienced a near syncopal episode. Patient accompanied by husband. Patient assisted to a laying position with legs propped-up. After several minutes patient able to sit up on her own, water given. Patient able to slowly transfer self from floor to chair without difficulty. Graham crackers given and encouraged to continue drinking water. Patient recovered and able to leave facility without difficulty. Patient exited facility approximately 45 minutes after vaccine administration.
After 3 minutes,,I felt palpitations-weak-shaking. I went to the ER  right away. for the first dose..I felt the same and I went to urgent care right away.
had a "protein thing" around her heart; BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) subcutaneously; blood pressure to go "sky high"; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) subcutaneously on 01Apr2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient would like to know the percentage of BNT162b2 that was in her system after one dose. She spoke with one physician who told her that she was 50% covered and another who told her it was 80%. The first dose of the vaccine caused her blood pressure to go "sky high" in Apr2021 and reported she almost passed out. She was taken to the emergency room where it was found that she had a "protein thing" around her heart that the doctors were not sure came from the vaccine or not. Due to this reaction, the patient was unsure if she would be able to get the second dose and would like to know how protected she was with just the first dose. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient is complaining of left arm soreness that has lasted for over a month after administration of SHINGRIX. She stated that it is still sore to the touch and hurts to lay on that arm while sleeping. She also stated that the pain sometimes radiates up to the shoulder.
I had what I thought was an upper respiratory issue in October of 2022. I realize now that it was a case of COVID-19. I didn't realize that a faint pink line was still considered positive. I developed a cough at that time and that has lasted since then. I woke up around 05:00AM ET on 12/26/2022 and was feeling tired and achy. The symptoms continued on throughout the day and by the end of the day, it had hit me really hard. I tested bright pink positive, and the upper respiratory symptoms were worse this time as soon as it hit. I had stomach problems, fever, and severe nasal congestion. My coughing was still bad, but it did not get worse than it was in the fall. It was just harsh and did not seem to respond to any medication. I've been tested for allergy issues, pulmonary issues and other testing. This cough causes severe stomach issues and fatigue. I have continued taking anti-depressants and the occasional anti-anxiety pill because I've been locked in the house. I'm being treated with inhalers, but when it gets bad, nothing seems to help in any way. I just can't catch my breath. The stomach issues just come and go, and I will get sudden diarrhea. I am used to being outdoors and have a horse, but I haven't been able to get to the farm since the fall. I coughed so hard on Thanksgiving that it caused eye problems. This has been a devastating few months. My doctor believes it is long COVID-19 at this point. I've tested negative for everything else.
THE DAY FOLLOWING THE VACCINE, I HAD A FEVER, NAUSEA, BODY ACHES, EXHAUSTION, AND AN EXTREMELY PAINFUL RIGHT ARM.   I DID HAVE ACTIVE COVID,  FEBRUARY 3RD THROUGH ABOUT FEBRUARY 15TH.   DURING THAT TIME, I HAD MANY OF THE COVID SYMPTOMS, BUT I DID NOT HAVE THE NAUSEA OR BODY ACHES, AS I DID ON MARCH 27TH.   I AM NOT COMPLAINING ABOUT MY SIDE EFFECTS.   THE INFORMATION LETTER I RECEIVED AT THE TIME OF MY VACCINE, SAID TO REPORT SIDE EFFECTS TO THIS WEBSITE, SO I AM.    I AM HAPPY TO HAVE BEEN ABLE TO RECEIVE THE VACCINE, AND I FEEL THE DAY OF SIDE EFFECTS WAS WORTH IT KNOWING, MY ANTIBODIES WERE ALREADY THERE IN FULL FORCE!  I AM FINE NOW AND AM LOOKING FORWARD  (I THINK....) TO MY NEXT VACCINE!
Information was received on 11-JUL-2017 from a medical assistant regarding multiple unspecified patients (age and gender not reported). Medical history, concurrent conditions and concomitant medications were not reported. On unspecified dates, the patients were administered improperly stored vaccines including VAQTA (lot # M047658, exp 28-OCT-2017), RECOMBIVAX (lot # M026309, exp 11-NOV-2018), GARDASIL 9 (lot # M032650, exp 31-MAR-2019), and ROTATEQ (lot # M029251, exp 14-MAR-2018) (doses, route, site of administration for all not reported).  The reporter was unable to provide the lot # and exp date for the properly stored sterile diluent that was used to reconstitute the vaccines. No adverse effects were reported. Temperature 47 degrees Fahrenheit to 77 degrees Fahrenheit. Time frame 56 minutes. Previous temperature excursion? No. Was call because of a data logger? Yes. Additional information has been requested.
Feels very cold and restless with no fever. She is currently in bed and we are waiting to see if if passes soon. She didn't sleep well and now is very restless and on the verge of tears.
Two days after my vaccine, I developed a lump on the same arm as the injection, on the inside of my elbow.  Anytime I touch something, from elbow to wrist, I get a tingly and burning sensation. I sent a message to my doctor.  His nurse called back and said it is a reaction to the shot and I don't need to do anything.
Patient reported that a "red streaky" reaction occurred 3-4 inches below her injection site on her left arm. She has used Naproxen twice daily to decrease swelling and has applied a heating pad to site.
Fever up to 102 and migraine for 2 days. Headache and fatigue for a week. Irritability and depression for 2 weeks.
ACUTE NON ST ELEVATION MI 10/30/2021 DM 2 CONTROLLED BY DIET
Patient complained of numbness in tongue and tingling around the mouth.  Vital signs were taken.  Patient remained COA X4.  Patient was transported to Hospital via Ambulance.
Full body aches and pains, fever, chills, sweats, severe headache, nausea, chest pain/pressure, fatigue but not being able to sleep due to intense pain.
This spontaneous report as received from a vaccine coordinator refers to a patient of unknown age and gender. No medical history and concurrent condition were reported. On 14-JAN-2019, the patient was vaccinated with an improperly stored first dose of PROQUAD (lot # R020677, expiry date 15-JAN-2020) for prophylaxis. The suspect vaccine was reconstituted with an properly stored sterile diluent. The vaccine was exposed to the temperature of -14.6 degree Celsius (C) for 30 minutes. Previous excursion included exposure to 0.1 C for 2 hours and -13.7 C for 45 minutes. A data logger was involved. No adverse effects were reported. No product quality complaint was present. This is one of the several reports received from same reporter source. Sender's Comments: US-009507513-1901USA006017.